PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Departments of Medicine (Endocrinology) and Neurological Surgery and Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA.\', \'Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands.\', \'Department of Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands.\', \'Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.\', \'Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.\', \'Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK.\', \'Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1530/EJE-20-0473EJE-20-0473
?:doi
?:hasPublicationType
?:journal
  • European journal of endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 32369770
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.892
?:rankingScore_hIndex
  • 126
?:title
  • Endocrinology in the time of COVID-19: Management of pituitary tumours.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all